Preferential Involvement of Tim-3 in the Regulation of Hepatic CD8+ T Cells in Murine Acute Graft-versus-Host Disease1
暂无分享,去创建一个
H. Tajiri | M. Zeniya | K. Okumura | Tsunekazu Oikawa | M. Azuma | H. Yagita | H. Akiba | Hiroki Takahashi | Yosuke Kamimura
[1] Y. Nakanuma,et al. Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. IV. A study of lymphocyte-endothelial interaction. , 2008, Liver.
[2] K. Omura,et al. Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. , 2006, Oral oncology.
[3] H. Geng,et al. Soluble Form of T Cell Ig Mucin 3 Is an Inhibitory Molecule in T Cell-Mediated Immune Response1 , 2006, The Journal of Immunology.
[4] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[5] G. McCaughan,et al. Intrahepatic immunity: a tale of two sites? , 2005, Trends in immunology.
[6] V. Kuchroo,et al. Tim-2 regulates T helper type 2 responses and autoimmunity , 2005, The Journal of experimental medicine.
[7] V. Kuchroo,et al. The TIM gene family regulates autoimmune and allergic diseases. , 2005, Trends in molecular medicine.
[8] V. Kuchroo,et al. TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation , 2005, Nature Immunology.
[9] G. Berry,et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance , 2005, Nature Immunology.
[10] D. Umetsu,et al. Regulation of Tolerance in the Respiratory Tract: TIM‐1, Hygiene, and the Environment , 2004, Annals of the New York Academy of Sciences.
[11] D. Adams,et al. The composition of intrahepatic lymphocytes: shaped by selective recruitment? , 2004, Trends in immunology.
[12] G. McCaughan,et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.
[13] D. Umetsu,et al. TIM-1, a novel allergy and asthma susceptibility gene , 2004, Springer Seminars in Immunopathology.
[14] V. Kuchroo,et al. Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance , 2003, Nature Immunology.
[15] G. Freeman,et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance , 2003, Nature Immunology.
[16] H. Kikutani,et al. Immune semaphorins: a new area of semaphorin research , 2003, Journal of Cell Science.
[17] G. Freeman,et al. The TIM gene family: emerging roles in immunity and disease , 2003, Nature Reviews Immunology.
[18] M. J. Abedin,et al. Selective Eosinophil Adhesion to Fibroblast Via IFN-γ-Induced Galectin-9 , 2002, The Journal of Immunology.
[19] S. Sakoda,et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2 , 2002, Nature.
[20] S. Yagihashi,et al. Interferon‐γ stimulates the expression of galectin‐9 in cultured human endothelial cells , 2002, Journal of Leukocyte Biology.
[21] Tatyana Chernova,et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease , 2002, Nature.
[22] G. Barsh,et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family , 2001, Nature Immunology.
[23] H. Hashimoto,et al. Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases1 , 2001, The Journal of Immunology.
[24] A. Ogata,et al. The role of donor T cells for target organ injuries in acute and chronic graft‐versus‐host disease , 2001, Immunology.
[25] K. Matsushima,et al. Mammalian and Viral IL-10 Enhance C-C Chemokine Receptor 5 but Down-Regulate C-C Chemokine Receptor 7 Expression by Myeloid Dendritic Cells: Impact on Chemotactic Responses and In Vivo Homing Ability1 , 2001, The Journal of Immunology.
[26] B. Fazekas de St. Groth,et al. Antigen-Specific Primary Activation of CD8+ T Cells Within the Liver1 , 2001, The Journal of Immunology.
[27] S. Mogi,et al. Rapid induction of CD95 ligand and CD4+ T cell‐mediated apoptosis by CD137 (4–1BB) costimulation , 2001, European journal of immunology.
[28] N. Chao,et al. Acute graft-vs-host disease: pathobiology and management. , 2001, Experimental hematology.
[29] Hiroaki Miyajima,et al. Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells1 , 2000, The Journal of Immunology.
[30] K. Matsushima,et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. , 1999, The Journal of clinical investigation.
[31] F. Finkelman,et al. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. , 1998, Journal of immunology.
[32] A. Kumar,et al. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. , 1997, The Journal of clinical investigation.
[33] Y. Kanwar,et al. Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin* , 1997, The Journal of Biological Chemistry.
[34] P. Matzinger. The JAM test. A simple assay for DNA fragmentation and cell death. , 1991, Journal of immunological methods.
[35] A. Nonomura,et al. HISTOLOGICAL CHANGES OF BILE DUCT IN EXPERIMENTAL GRAFT‐VERSUS‐HOST DISEASE ACROSS MINOR HISTOCOMPATIBILITY BARRIERS , 1987, Acta pathologica japonica.
[36] K. Sullivan,et al. Intestinal and hepatic complications of human bone marrow transplantation. Part I. , 1986, Gastroenterology.
[37] I. N. Crispe,et al. Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.
[38] H. Watanabe,et al. Details of an isolation method for hepatic lymphocytes in mice. , 1992, Journal of immunological methods.
[39] G. Shearer,et al. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. , 1988, Immunology today.
[40] R. Renkonen. Immunobiology of acute graft-versus-host disease. , 1987, Medical biology.